In a recent analysis of 1262 patients, expression of ERβ by immunohistochemistry correlated with prognosis in CRC: decreased expression was found in larger tumors of higher grade, and expression levels were also inversely correlated with Dukes stage. This evidence concerns the gene ESR2 and colorectal carcinoma.